idarubicin has been researched along with Libman-Sacks Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capria, S; Mandelli, F; Meloni, G; Modena, V; Vignetti, M | 1 |
| Berrebi, A; Levene, NA | 1 |
2 other study(ies) available for idarubicin and Libman-Sacks Disease
| Article | Year |
|---|---|
Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Blast Crisis; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Idarubicin; Immunologic Factors; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lupus Erythematosus, Systemic; Methotrexate; Prednisone; Remission Induction; Transplantation, Autologous; Vincristine | 1997 |
Systemic lupus erythematosus associated with refractory anemia with excess of blasts.
Topics: Aged; Anemia; Blood Transfusion; Humans; Idarubicin; Leukocyte Count; Lupus Erythematosus, Systemic; Male; Platelet Count | 1990 |